Amarin’s Vascepa cuts occurrence of serious heart problems 30 percent: study

110

A high dose of Amarin Corp’s Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart attacks, strokes and other serious heart problems in high-risk patients already taking cholesterol medication by even more than initially reported, according to data presented on Monday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/FA637e6g0U4/amarins-vascepa-cuts-occurrence-of-serious-heart-problems-30-percent-study-idUSKCN1QZ1I4